Home » Public Policy

Stewardship

2013 Policy Principles to Promote Biotechnology

Biotechnology helps societies solve old problems in new ways. Through the science of using living cells and the discovery of new molecules, biotech innovation provides societies with innovative means to address their most urgent needs: fighting disease, feeding the hungry, and improving the environment.

2012 BIO International Convention Governors Highlight Reel

The 2012 BIO International Convention featured a broad array of top-level speakers, addressing critical global challenges and the top issues in biotechnology. Hosted by the Biotechnology Industry Organization (BIO), the event drew 16,505 industry leaders from 65 countries.

Product Launch Stewardship: Food and Agriculture Section

Through its advocacy efforts, BIO’s Food and Agriculture Section supports a regulatory framework that facilitates and enables the development and commercialization of new biotechnology-derived plant products.

Podcast: Scientific American Worldview Report and Scorecard Preview, Part One

In this two part series, Scientific American’s Jeremy Abbate talks to editors Mike May and Yali Friedman about the Worldview Report and Scorecard, which will be released at the upcoming BIO International Convention in Boston at a Super Session on June 19.

Podcast: Scientific American Worldview Report and Scorecard Preview, Part Two

In this two part series, Scientific American’s Jeremy Abbate talks to editors Mike May and Yali Friedman about the Worldview Report and Scorecard, which will be released at the upcoming BIO International Convention in Boston at a Super Session on June 19.

Phyllis Dillinger, Women in Bio

Phyllis discusses the importance of making connections in the industry to propel women into leadership roles, and plans for the upcoming BIO International Convention in Boston, Mass. On June 18-21.

The Life Sciences Foundation

BIO President and CEO Jim Greenwood talks with Arnold Thackray, President and CEO of the Life Sciences Foundation, about how the life sciences will shape the course of the 21st century.

Laura Shawver, PhD, CEO, Cleave Biosciences

Dr. Shawver discusses why this is an exciting time for the industry, and her experiences as a bench scientist turned CEO and founder of a patient advocacy group.

Bob Coughlin of MassBio Talks Innovation

Bob Coughlin discusses the elements of supportive bioscience industry climates and looks ahead to the 2012 BIO International Convention.

Ron Cohen, President and CEO, Acorda Therapeutics, Inc.

Dr. Cohen discusses the plight of today’s emerging biotech companies, and how the federal government can best support innovation within the industry.

Podcast: BIO Media Briefing Highlights 2012 Policy Priorities

BIO President & CEO Jim Greenwood and Tom Watkins, President & CEO of Human Genome Sciences and Chair of BIO’s Board of Directors, recently hosted a media briefing to recap our advocacy accomplishments in 2011 and lay out BIO’s policy priorities for 2012.

60 Pavilions Showcase Countries, Regions and States at the 2012 BIO International Convention

Pavilions attract attendees and media alike, affording a space to tell your story within the context of a particular geographic region or specific focus area.

Capital Formation Spurs Job Growth

Congress has the opportunity to help speed lifesaving cures and treatments to patients by removing burdens to innovation in our industry.

The Power of Partnering, Expanded

Where can you network and partner with 15,000+ industry leaders from 65 countries across the globe?

Discovery to Step Out of the Shadows at BIO Investor Forum

There are many reasons to be excited about financing early stage biotech companies. The BIO Investor Forum will assemble the most promising among promising discovery stage companies. 

Letters, Testimony & Comments

BIO Principles on Patient Safety in the Substitution of Biologic Products
January 24 2013
Biologics are complex medicines manufactured from living organisms. Unlike traditional “small molecule” drugs, biologics are...
Stewardship: Actions to be Taken Prior to Launching Special Traits
October 4 2010
Dear Secretary Vilsack: For the past 15 years, agricultural products derived from modern biotechnology have provided significant...
BIO’s comments to the USDA on the biomass crop assistance program enacted by the 2008 Farm Bill
The Biotechnology Industry Organization (BIO) appreciates the opportunity to provide comments on the proposed regulations to implement...

Press Releases

Scientific American to Host BIO International Convention Super Session to Release 4th Annual Worldview Report and Scorecard Highlighting Emerging Markets
June 6 2012
Washington, DC and New York, NY, Wednesday, June 6, 2012 -The 4th Annual Scientific American Worldview Report and...
BIO Announces Expansion of Alliance Development Activities
March 2 2012
WASHINGTON, D.C. (March 2, 2012) – The Biotechnology Industry Organization (BIO) announced today that it has...
Release of FDA Guidance for Biosimilars Pathway Marks Important Step Forward, Says BIO
February 9 2012
Patient Safety Must Remain Top Priority Washington, D.C. (February 9, 2012) — Biotechnology Industry...
BIO Applauds the Intent to Create a National Bioeconomy Blueprint
October 13 2011
Washington, D.C. (October 13, 2011) – Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood...
BIO Statement on U.S. District Court Ruling in “Eucalyptus” Case
October 7 2011
Washington, D.C. (October 7, 2011) – In a case brought against USDA’s Animal and Plant Health Inspection...
More Press Releases →